From: Akira Koide <akirak@newtarget.com>
To: "'Sahadzic, Sanjin'" <Sanjin.Sahadzic@justice.org>
Cc: 'ashish pagar' <ashishpagar@gmail.com>, "'Diakhate, Khadime'" <Khadime.Diakhate@justice.org>, 'Pedja Grujic' <pedjag@newtarget.com>
Sent: 10/2/2015 9:15 AM
Subject: RE: solr hook update

I have checked the data of Solr side and found exchange_date2 is not populated there for most of nodes.
They don’t show up once you filter by date.
We need to re-index to have Solr collect exchange_date2 from all nodes.
Once we do, it should work as expected.

For example, this node 10973 doesn’t have exchange_date2.
      {
        "id": "l3olzx/node/10973",
        "site": "https://weblab.justice.org/",
        "hash": "l3olzx",
        "entity_id": 10973,
        "entity_type": "node",
        "bundle": "document",
        "bundle_name": "Document",
        "ss_language": "und",
        "path": "node/10973",
        "url": "https://weblab.justice.org/document/propeciaproscar",
        "path_alias": "document/propeciaproscar",
        "label": "Propecia/Proscar",
        "spell": [
          "Propecia/Proscar",
          " $325.00 90 108 338 Litigation Packet 295 • Provides an overview of Propecia and its link to sexual dysfunction, prostate cancer, and male breast cancer • Discusses the science behind Propecia, its development by Merck, and the biological effects of the drug • Information on case screening including sample client questionnaires, case selection criteria, and statute of limitations considerations • Includes sample complaints and information on the Propecia multidistrict litigation • AAJ Education speaker papers, FDA materials, and a bibliography of medical journals Hot Topics Sunday, October 16, 2011- 20:00 Tuesday, July 16, 2013- 20:00 Propecia, finasteride, merck, testosterone, male pattern hair loss, bald, baldness, DHT, 5-alpha reductase, sexual dysfunction, prostate cancer, male breast cancer, erectile dysfunction, proscar, multidistrict litigation, MDL, multi-district litigation 10973.pdf Toxic and Pharmaceutical Torts 90108338.pdf ",
          "Litigation Packet"
        ],
        "content": " $325.00 90 108 338 Litigation Packet 295 • Provides an overview of Propecia and its link to sexual dysfunction, prostate cancer, and male breast cancer • Discusses the science behind Propecia, its development by Merck, and the biological effects of the drug • Information on case screening including sample client questionnaires, case selection criteria, and statute of limitations considerations • Includes sample complaints and information on the Propecia multidistrict litigation • AAJ Education speaker papers, FDA materials, and a bibliography of medical journals Hot Topics Sunday, October 16, 2011- 20:00 Tuesday, July 16, 2013- 20:00 Propecia, finasteride, merck, testosterone, male pattern hair loss, bald, baldness, DHT, 5-alpha reductase, sexual dysfunction, prostate cancer, male breast cancer, erectile dysfunction, proscar, multidistrict litigation, MDL, multi-district litigation 10973.pdf Toxic and Pharmaceutical Torts 90108338.pdf ",
        "teaser": " $325.00 90 108 338 Litigation Packet 295 • Provides an overview of Propecia and its link to sexual dysfunction, prostate cancer, and male breast cancer • Discusses the science behind Propecia, its development by Merck, and the biological effects of the drug • Information on case screening including",
        "ss_name": "bluewatermedia",
        "tos_name": "bluewatermedia",
        "ss_name_formatted": "bluewatermedia",
        "tos_name_formatted": "bluewatermedia",
        "is_uid": 1,
        "bs_status": true,
        "bs_sticky": false,
        "bs_promote": true,
        "is_tnid": 0,
        "bs_translate": false,
        "ds_created": "2014-02-06T16:28:04Z",
        "ds_changed": "2015-07-20T14:42:49Z",
        "ds_last_comment_or_change": "2015-07-20T14:42:49Z",
        "itm_field_document_id": [
          90108338
        ],
        "its_field_document_id": 90108338,
        "im_field_tags": [
          19
        ],
        "tid": [
          19
        ],
        "im_vid_1": [
          19
        ],
        "sm_vid_Tags": [
          "Litigation Packet"
       ],
        "tm_vid_1_names": [
          "Litigation Packet"
        ],
        "itm_field_page_count": [
          295
        ],
        "its_field_page_count": 295,
        "bm_field_restricted_status": [
          false
        ],
        "bs_field_restricted_status": false,
        "bm_field_need_agreement": [
          false
        ],
        "bs_field_need_agreement": false,
        "sm_field_packet_type": [
          "1"
        ],
        "dm_field_date_updated": [
          "2013-07-17T00:00:00Z"
        ],
        "exchange_date": [
          "2013-07-17T00:00:00Z"
        ],
        "bm_field_previously_testified": [
          false
        ],
        "bs_field_previously_testified": false,
        "bm_field_resume": [
          false
        ],
        "bs_field_resume": false,
        "bm_field_approved": [
          false
        ],
        "bs_field_approved": false,
        "sm_field_subject_category": [
          "59"
        ],
        "bm_field_show_dashboard": [
          false
        ],
        "bs_field_show_dashboard": false,
        "bm_field_listing": [
          true
        ],
        "bs_field_listing": true,
        "_version_": 1509998170999881700,
        "timestamp": "2015-08-20T04:54:33.461Z"
      },

Whereas this node has.
      {
        "id": "l3olzx/node/79955",
        "site": "http://default/",
        "hash": "l3olzx",
        "entity_id": 79955,
        "entity_type": "node",
        "bundle": "document",
        "bundle_name": "Document",
        "ss_language": "und",
        "path": "node/79955",
        "url": "http://default/document/letter-hon-glenn-grant-gregory-s-spizer-anapol-schwartz-re-response-joint-request",
        "path_alias": "document/letter-hon-glenn-grant-gregory-s-spizer-anapol-schwartz-re-response-joint-request",
        "label": "Letter to Hon. Glenn A. Grant from Gregory S. Spizer of Anapol Schwartz, re: Response to the Joint Request for Reconsideration of Designation of Mirena",
        "spell": [
          "Letter to Hon. Glenn A. Grant from Gregory S. Spizer of Anapol Schwartz, re: Response to the Joint Request for Reconsideration of Designation of Mirena",
          " $50.00 90 114 512 Court Document MR: Mirena IUD Other NA: Not Applicable Electronic N/a Monday, March 11, 2013- 20:00 Carmen Scott NOT AVAILABLE MIUD0014.pdf 1710 Spruce Street Philadelphia, PA 19103 Anapol Schwartz 1040 Kings Highway North Suite 304 ATTORNEYS AT LAW Civil Practice Division Cherry Hill, NJ 08034 252 Boas Street Gregory S. Spizer, Esquire MAR 15 2009 Harrisburg, PA 17102 1040 Kings Highway North 8700 East Vista Bonita Drive Suite 304 Suite 228 Cherry Hill, NJ 08034 RECEIVED Scottsdale, AZ 85255 gspizer@anapolschwartz.com 866·735·2792 Toll Free www.AnapolSchwartz.com (856) 382-1302 Direct Dial (215) 875-7722 Direct Fax March 12,2013 *VIA HAND DELIVERY* Hon. Glenn A. Grant, J.A.D. Acting Administrative Director of the Courts Administrative Office of the Courts Richard J. Hughes Justice Complex 25 West Market Street Trenton, New Jersey 08625 RE: Response to the Joint Request for Reconsideration ofDesignation ofMirena® Litigation as a Multicounty Litigation for Centralized Management Dear Judge Grant: Our office represents Plaintiff, Tammy DeLeon, whose case is currently pending in the Superior Court ofNew Jersey, Bergen County, Docket Number: BER-L-1605-13. Ms. DeLeon's lawsuit involves the Mirena® intrauterine contraceptive device ("Mirena®"). We submit this letter in response to the Joint Requests for Reconsideration of Designation of Mirena@ Litigation as a Multicounty Litigation for CentrHiizerl JV!anagem0nt whkh were recently filed by both representatives ofPlaintiffs and the named Defendants, Bayer Healthcare Pharmaceuticals, Inc. and other Bayer entities. Both parties seek to have the New Jersey Mirena@ litigation designated as a multicounty litigation-one notable distinction in the applications is that Plaintiffs take no position on which vicinage the motion should be assigned while Defendants seek centralization in Middlesex County. The undersigned does not object to the centralized management ofthe Mirena litigation, but does respectfully request that the cases instead be consolidated for centralized management before the Honorable Brian R. Martinotti in Bergen County. Anapol Schwartz March 12,2013 Page2 I. THE J>ARTIES The Defendants in these products liability cases are Bayer Healthcare Pharmaceuticals, Inc., and a number of additional Bayer related entities (collectively "Bayer"). Bayer's principal place of business is located in Morris County. The plaintiffs are individuals who hale from New Jersey as well as other states. To date, a number of Mirena® complaints have been filed in Morris, Essex and Bergen Counties. II. VENUE Consideration ofthe relevant factors-fairness, geography and existing case load-leads to the conclusion that Bergen County provides the most appropriate vicinage for centralized management. See Multicounty Litigation Guidelines and Criteria for Designation (September 4, 2012). A. JUDGE MARTINOTTI'S VAST EXPERIENCE OVERSEEING OTHER BIRTH CONTROL LITIGATIONS STRONGLY FAVORS BERGEN COUNTY AS THE FORUM FOR THIS MULTICOUNTY LITIGATION Over the last four years, Judge Matiinotti has managed two leading bitth control litigations: Yaz/Yasmin/Ocella (hereinafter "Yaz") and NuvaRing. The Yaz litigation, which also involves the Bayer Defendants, includes allegations that Yaz was associated with an increased risk of blood clots and strokes. The Yaz cases have been centralized in Bergen County since February 2010 and since that time, considerable attention has been paid to the science and mechanism of action of oral contraceptives. As a result ofextensive motion practice, numerous case management conferences and day-to-day oversight ofthe Yaz cases, Judge Martinotti obtained invaluable experience and expertise in this area of medicine. While the allegations in Mirena are not exactly the same as in Yaz, the medical tutorial that Judge Martinotti received on the subject ofbitth control will prove vital when scientific and medical issues invariably arise in the Mirena cases. This knowledge base of birth control products cannot be underestimated. Similarly, NuvaRing, a birth control product that is also alleged to cause blood clots and strokes, was designated as a multicounty litigation in Bergen County in March 2009. A NuvaRing bellwether trial is scheduled for later this year and in advance of that trial, Kemp motions and Motions for Summary Judgment have been briefed and prepared to be argued before Judge Martinotti. Although the allegations, injuries and warnings for Mirena are different than NuvaRing, birth control is, once again, the product at-issue. The background information that Judge Martinotti has been exposed to via the trial preparation process and current motion practice provides him with a huge lead at the slatting gate. Given Judge Mattinotti's experience with the relevant medical issues, there will be little learning curve and the Mirena® litigation will be up and running immediately. March 12, 2013 Page 3 Additionally, not only does Judge Martinotti have significant experience with birth control devices, claims and defenses-the Yaz litigation also provided Judge Martinotti with invaluable familiarity and insight concerning the defendant in the Mirena cases-Bayer. Issues concerning Bayer's document retention and production, its members, foreign workers and a general understanding of Bayer's policies and procedures are known to the Bergen County Court and, as such, can be much more easily addressed in light of this background knowledge. It is respectfully submitted that judicial resources are best served by appointing Judge Martinotti to manage this litigation when he and his staffalready possess a wealth of information and experience in the relevant subject areas. B. BAYER'S PRINICPALPLACE OF BUSINESS IS IN CLOSE PROXIMITY TO BERGEN COUNTY Both the Bergen County and Middlesex County courthouses are easily accessible from all major transportation hubs. While each comihouse is readily accessible, it should be noted that Bayer's principal place ofbusiness, as well as its central employees and documents, are located in Morris County. These facts are noteworthy as the Bergen County cou1ihouse is approximately half the distance from Bayer's principal place ofbusiness when compared to the Middlesex County courthouse. Due to the easy accessibility and close proximity to Defendants' principal place ofbusiness, Bergen County is the geographically superior location for all interested pmiies in these matters. C. THE MULTICOUNTY LITIGATION DOCKET SUPPORTS BERGEN COUNTY The Court's central· inquiry as to "the existing civil and mass tort caseload in the vicinage" favors Bergen County as well. Middlesex County currently presides over six (6) pharmaceutical/medical device multicounty litigations including AlloDerm Regenerative Tissue Matrix, Gadolinium, HRT, Propecia, Risperdal/Seroquel/Zyprexa, and Zometa/Aredia, while Bergen County presently presides over four (4) pharmaceutical/medical device litigations including Stryker Hip/ABG II Modular Hip Stem, DePuy ASR Hip Implant, NuvaRing, and Yaz/Yasmin/Ocella. The active multi-county caseload in Bergen County is 1,992 cases, which is only slightly higher than the 1,697 cases which make up the multi-county case load in Middlesex County. See New Jersey.Judicimy, CIVIL CASELOAD SUMMARY BY CASETYPE, July, 2012­.January, 2013, Middlesex and Bergen Counties http. www.judiciary.state.nj.us/guant/cman 130 l.pdf March 12, 2013 Page4 III. CONCLUSION For the foregoing reasons, Plaintiffs do not oppose the Mirena® litigation being centralized as a multicounty litigation in New Jersey but respectfully request that the management occur in Bergen County. Respectfully submitted, Gregory S. Spizer GSS/sdt cc: Couglin Duffy LLP Johnson Becker J>LLC Motley Rice, LLC Myers & Flowers LLC Heninger, Garrison Davis, LLC The Lanier Law Finn The Levensten Law Firm Other Saturday, December 13, 0003- 00:00 ",
          "Court Document"
        ],
        "content": " $50.00 90 114 512 Court Document MR: Mirena IUD Other NA: Not Applicable Electronic N/a Monday, March 11, 2013- 20:00 Carmen Scott NOT AVAILABLE MIUD0014.pdf 1710 Spruce Street Philadelphia, PA 19103 Anapol Schwartz 1040 Kings Highway North Suite 304 ATTORNEYS AT LAW Civil Practice Division Cherry Hill, NJ 08034 252 Boas Street Gregory S. Spizer, Esquire MAR 15 2009 Harrisburg, PA 17102 1040 Kings Highway North 8700 East Vista Bonita Drive Suite 304 Suite 228 Cherry Hill, NJ 08034 RECEIVED Scottsdale, AZ 85255 gspizer@anapolschwartz.com 866·735·2792 Toll Free www.AnapolSchwartz.com (856) 382-1302 Direct Dial (215) 875-7722 Direct Fax March 12,2013 *VIA HAND DELIVERY* Hon. Glenn A. Grant, J.A.D. Acting Administrative Director of the Courts Administrative Office of the Courts Richard J. Hughes Justice Complex 25 West Market Street Trenton, New Jersey 08625 RE: Response to the Joint Request for Reconsideration ofDesignation ofMirena® Litigation as a Multicounty Litigation for Centralized Management Dear Judge Grant: Our office represents Plaintiff, Tammy DeLeon, whose case is currently pending in the Superior Court ofNew Jersey, Bergen County, Docket Number: BER-L-1605-13. Ms. DeLeon's lawsuit involves the Mirena® intrauterine contraceptive device ("Mirena®"). We submit this letter in response to the Joint Requests for Reconsideration of Designation of Mirena@ Litigation as a Multicounty Litigation for CentrHiizerl JV!anagem0nt whkh were recently filed by both representatives ofPlaintiffs and the named Defendants, Bayer Healthcare Pharmaceuticals, Inc. and other Bayer entities. Both parties seek to have the New Jersey Mirena@ litigation designated as a multicounty litigation-one notable distinction in the applications is that Plaintiffs take no position on which vicinage the motion should be assigned while Defendants seek centralization in Middlesex County. The undersigned does not object to the centralized management ofthe Mirena litigation, but does respectfully request that the cases instead be consolidated for centralized management before the Honorable Brian R. Martinotti in Bergen County. Anapol Schwartz March 12,2013 Page2 I. THE J>ARTIES The Defendants in these products liability cases are Bayer Healthcare Pharmaceuticals, Inc., and a number of additional Bayer related entities (collectively "Bayer"). Bayer's principal place of business is located in Morris County. The plaintiffs are individuals who hale from New Jersey as well as other states. To date, a number of Mirena® complaints have been filed in Morris, Essex and Bergen Counties. II. VENUE Consideration ofthe relevant factors-fairness, geography and existing case load-leads to the conclusion that Bergen County provides the most appropriate vicinage for centralized management. See Multicounty Litigation Guidelines and Criteria for Designation (September 4, 2012). A. JUDGE MARTINOTTI'S VAST EXPERIENCE OVERSEEING OTHER BIRTH CONTROL LITIGATIONS STRONGLY FAVORS BERGEN COUNTY AS THE FORUM FOR THIS MULTICOUNTY LITIGATION Over the last four years, Judge Matiinotti has managed two leading bitth control litigations: Yaz/Yasmin/Ocella (hereinafter "Yaz") and NuvaRing. The Yaz litigation, which also involves the Bayer Defendants, includes allegations that Yaz was associated with an increased risk of blood clots and strokes. The Yaz cases have been centralized in Bergen County since February 2010 and since that time, considerable attention has been paid to the science and mechanism of action of oral contraceptives. As a result ofextensive motion practice, numerous case management conferences and day-to-day oversight ofthe Yaz cases, Judge Martinotti obtained invaluable experience and expertise in this area of medicine. While the allegations in Mirena are not exactly the same as in Yaz, the medical tutorial that Judge Martinotti received on the subject ofbitth control will prove vital when scientific and medical issues invariably arise in the Mirena cases. This knowledge base of birth control products cannot be underestimated. Similarly, NuvaRing, a birth control product that is also alleged to cause blood clots and strokes, was designated as a multicounty litigation in Bergen County in March 2009. A NuvaRing bellwether trial is scheduled for later this year and in advance of that trial, Kemp motions and Motions for Summary Judgment have been briefed and prepared to be argued before Judge Martinotti. Although the allegations, injuries and warnings for Mirena are different than NuvaRing, birth control is, once again, the product at-issue. The background information that Judge Martinotti has been exposed to via the trial preparation process and current motion practice provides him with a huge lead at the slatting gate. Given Judge Mattinotti's experience with the relevant medical issues, there will be little learning curve and the Mirena® litigation will be up and running immediately. March 12, 2013 Page 3 Additionally, not only does Judge Martinotti have significant experience with birth control devices, claims and defenses-the Yaz litigation also provided Judge Martinotti with invaluable familiarity and insight concerning the defendant in the Mirena cases-Bayer. Issues concerning Bayer's document retention and production, its members, foreign workers and a general understanding of Bayer's policies and procedures are known to the Bergen County Court and, as such, can be much more easily addressed in light of this background knowledge. It is respectfully submitted that judicial resources are best served by appointing Judge Martinotti to manage this litigation when he and his staffalready possess a wealth of information and experience in the relevant subject areas. B. BAYER'S PRINICPALPLACE OF BUSINESS IS IN CLOSE PROXIMITY TO BERGEN COUNTY Both the Bergen County and Middlesex County courthouses are easily accessible from all major transportation hubs. While each comihouse is readily accessible, it should be noted that Bayer's principal place ofbusiness, as well as its central employees and documents, are located in Morris County. These facts are noteworthy as the Bergen County cou1ihouse is approximately half the distance from Bayer's principal place ofbusiness when compared to the Middlesex County courthouse. Due to the easy accessibility and close proximity to Defendants' principal place ofbusiness, Bergen County is the geographically superior location for all interested pmiies in these matters. C. THE MULTICOUNTY LITIGATION DOCKET SUPPORTS BERGEN COUNTY The Court's central· inquiry as to "the existing civil and mass tort caseload in the vicinage" favors Bergen County as well. Middlesex County currently presides over six (6) pharmaceutical/medical device multicounty litigations including AlloDerm Regenerative Tissue Matrix, Gadolinium, HRT, Propecia, Risperdal/Seroquel/Zyprexa, and Zometa/Aredia, while Bergen County presently presides over four (4) pharmaceutical/medical device litigations including Stryker Hip/ABG II Modular Hip Stem, DePuy ASR Hip Implant, NuvaRing, and Yaz/Yasmin/Ocella. The active multi-county caseload in Bergen County is 1,992 cases, which is only slightly higher than the 1,697 cases which make up the multi-county case load in Middlesex County. See New Jersey.Judicimy, CIVIL CASELOAD SUMMARY BY CASETYPE, July, 2012­.January, 2013, Middlesex and Bergen Counties http. www.judiciary.state.nj.us/guant/cman 130 l.pdf March 12, 2013 Page4 III. CONCLUSION For the foregoing reasons, Plaintiffs do not oppose the Mirena® litigation being centralized as a multicounty litigation in New Jersey but respectfully request that the management occur in Bergen County. Respectfully submitted, Gregory S. Spizer GSS/sdt cc: Couglin Duffy LLP Johnson Becker J>LLC Motley Rice, LLC Myers & Flowers LLC Heninger, Garrison Davis, LLC The Lanier Law Finn The Levensten Law Firm Other Saturday, December 13, 0003- 00:00 ",
        "teaser": " $50.00 90 114 512 Court Document MR: Mirena IUD Other NA: Not Applicable Electronic N/a Monday, March 11, 2013- 20:00 Carmen Scott NOT AVAILABLE MIUD0014.pdf 1710 Spruce Street Philadelphia, PA 19103 Anapol Schwartz 1040 Kings Highway North Suite 304 ATTORNEYS AT LAW Civil Practice Division Cherry",
        "ss_name": "bluewatermedia",
        "tos_name": "bluewatermedia",
        "ss_name_formatted": "bluewatermedia",
        "tos_name_formatted": "bluewatermedia",
        "is_uid": 1,
        "bs_status": true,
        "bs_sticky": false,
        "bs_promote": true,
        "is_tnid": 0,
        "bs_translate": false,
        "ds_created": "2014-04-04T02:14:41Z",
        "ds_changed": "2015-06-24T19:49:48Z",
        "ds_last_comment_or_change": "2015-06-24T19:49:48Z",
        "itm_field_document_id": [
          90114512
        ],
        "its_field_document_id": 90114512,
        "im_field_tags": [
          14
        ],
        "tid": [
          14
        ],
        "im_vid_1": [
          14
        ],
        "sm_vid_Tags": [
          "Court Document"
        ],
        "tm_vid_1_names": [
          "Court Document"
        ],
        "sm_field_contributor": [
          "195"
        ],
        "sm_field_document_type": [
          "58"
        ],
        "sm_field_jurisdiction": [
          "166"
        ],
        "sm_field_media_type": [
          "E"
        ],
        "sm_field_docket_number": [
          "N/a"
        ],
        "dm_field_filing_date": [
          "2013-03-12T00:00:00Z"
        ],
        "exchange_date": [
          "2013-03-12T00:00:00Z",
          "0003-12-13T00:00:00Z"
        ],
        "sm_field_lead_counsel": [
          "Carmen Scott"
        ],
        "sm_field_lead_counsel_city": [
          ""
        ],
        "sm_field_lead_counsel_state": [
          "UN"
        ],
        "bm_field_restricted_status": [
          true
        ],
        "bs_field_restricted_status": true,
        "bm_field_need_agreement": [
          false
        ],
        "bs_field_need_agreement": false,
        "bm_field_previously_testified": [
          false
        ],
        "bs_field_previously_testified": false,
        "bm_field_resume": [
          false
        ],
        "bs_field_resume": false,
        "bm_field_approved": [
          false
        ],
        "bs_field_approved": false,
        "sm_field_source_link": [
          "node:11078"
        ],
        "sm_field_court_document_type": [
          "58"
        ],
        "dm_field_exchange_date2": [
          "0003-12-13T00:00:00Z"
        ],
        "_version_": 1510162368044204000,
        "timestamp": "2015-08-22T00:24:23.953Z"
      },

Thanks,

Akira